•Part 1: History of GBCA Use - An overview - by Pr. Thoeny (Switzerland)
•Part 2: AI and Image Reconstruction - by Dr. Tanenbaum (USA)
•Part 3: Future of GBCA and other Contrast Media Strategies - by Dr. Raynaud (France)
Moderated by Pr. Thoeny (Switzerland)
•Part 1: State of the art in Prostate Cancer Imaging - by Dr. Barrett (UK)
•Part 2: Future of AI for Prostate Cancer Management - by Pr. Petralia (Italy)
•Part 3: Q&A session - led by Pr. Thoeny (Switzerland)
Moderated by Pr. Thoeny (Switzerland)
•Part 1: Breast imaging from a pro-MRI perspective - by Dr. Helbich (Austria)
•Part 2: Breast imaging from a pro-CEM perspective - by Dr. Lobbes (Netherlands)
•Part 3: Q&A session - led by Dr.Klifa (France)
Moderated by Dr. Klifa (France)
Speaker: Dr. Baptista
Speaker: Dr. Lobbes
Speaker: Dr. Lancelot
Speaker: Dr. Shahid
A sneak-peek from ECR 2022
📍 Guerbet continues to innovate with you and for you, building lasting relationships that support you at every step of the patient pathway. With artificial intelligence and tailored solutions, Guerbet also introduced a brand-new innovation bringing the future of MRI into focus.
Inspired by innovation. Guided by Guerbet.
Listen to David Hale, Guerbet CEO, and Pr. Harriet Thoeny, Chair of Radiology and Professor at the University of Fribourg (Switzerland), share their first impressions and expectations for this new edition of 2022.
P22001361